Different Safety Pattern of an Inactivated SARS-CoV-2 Vaccine (CoronaVac^®) According to Age Group in a Pediatric Population from 3 to 17 Years Old, in an Open-Label Stud... by Nicole Le Corre, Katia Abarca, Patricio Astudillo, Marcela Potin, Sofía López, Macarena Goldsack, Vania Valenzuela, Andrea Schilling, Victoria Gaete, Lilian Rubio, Mario Calvo, Loreto Twele, Marcela González, Daniela Fuentes, Valentina Gutiérrez, Felipe Reyes, Lorena I. Tapia, Rodolfo Villena, Angello Retamal-Díaz, Antonio Cárdenas, Eduardo Alarcón-Bustamante, Xing Meng, Qianqian Xin, José V. González-Aramundiz, María Javiera Álvarez-Figueroa, Pablo A. González, Susan M. Bueno, Jorge A. Soto, on behalf of the PedCoronaVac03CL Study Group, Cecilia Perret, Alexis M. Kalergis

Subjects: “…CoronaVac^®…”
Get full text

Safety and Non-Inferiority Evaluation of Two Immunization Schedules with an Inactivated SARS-CoV-2 Vaccine in Adults: A Randomized Clinical Trial by Katia Abarca, Carolina Iturriaga, Marcela Urzúa, Nicole Le Corre, Augusto Pineda, Carolina Fernández, Angélica Domínguez, Pablo A. González, Susan M. Bueno, Paulina Donato, Pilar Espinoza, Daniela Fuentes, Marcela González, Paula Guzmán, Paula Muñoz-Venturelli, Carlos M. Pérez, Marcela Potin, Álvaro Rojas, José V. González-Aramundiz, Nicolás M. S. Gálvez, Francisca Aguirre-Boza, Sofía Aljaro, Luis Federico Bátiz, Yessica Campisto, Mariela Cepeda, Aarón Cortés, Sofía López, María Loreto Pérez, Andrea Schilling, Alexis M. Kalergis, on behalf of the CoronaVac03CL Study Group

Subjects: “…CoronaVac^®…”
Get full text